Avicanna sales flat in the third quarter, cash concerns persist
The drugmaker’s Colombian licensing deals helped drive a sevenfold jump in South American revenue. Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) managed to lift its margins while posting flat revenue in the third quarter as summer sales slowed. Revenue reached C$6.3 million for the three months ended Sept. 30, a marginal 0.34% increase from C$6.25 million […]
